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1. IntroductIon
A number of individuals travel to high altitude terrains 
either for work or for recreational activities1,2. Mountain 
climate is a unique challenge to human body due to reduction 
in barometric pressure which in-turn leads to decrease in 
oxygen per breath. Reduced breathable oxygen causes 
low blood and tissue oxygen saturation3-5. A number of 
compensatory responses occur in the body that enable humans 
to tolerate this reduced oxygen availability, which comes under 
acclimatisation process. Increase in heart rate and ventilation 
is an important feature of high altitude acclimatisation. Lung 
plays an indispensable role in this process and is one of the 
primary organs in the series of physiological response. Role of 
lung in altitude exposure came to light in 1893, where changes 
in lung volume and ventilation were discussed6. Respiratory 
system is variably affected at high altitude and plays a 
significant role during high altitude hypoxia. To measure 
changes in lung function; spirometry is known to be the most 
common and widely employed test7,8. It is used to measure 
timed inspired and expired volumes and is most common of 
pulmonary function tests. Forced vital capacity (FVC) has been 
shown to decrease, both at high altitude and using simulated 
high altitude conditions. A few airflow parameters have been 
shown to improve upon high altitude exposure, which may be 
due to reduction in air density9. There have been contradicting 
studies in the trend of forced expiratory volume in 1 s (FEV1) 
and maximum voluntary ventilation (MVV) upon high altitude 
exposure1. 
Effect of altitude and duration of exposure on lung 
function variables on healthy male volunteers with the purpose 
of understanding respiratory function in mountainous regions 
has been investigated.
2.  MaterIal and Methods
2.1  study Volunteers and Protocol
Initially 20 healthy male of the age group 21-30 years, 
height 1.73 m ±0.07 m and weight 66.72 kg ±1.4 kg of Indian 
Army were selected randomly for the study. The volunteers 
conformed to the procedure and an informed written consent was 
obtained from each of them after explaining detailed protocol of 
study. All the volunteers were non-smokers and non-alcoholic 
and were not exposed to high altitude environment previously. 
No previous history of respiratory disorder was there in any of 
the volunteer. During the study three volunteers were excluded 
due to mild cough and data were not considered for analysis. 
The study procedure was approved by Defence Institute of 
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Physiology and Allied Sciences, Delhi, Ethical Committee 
and were carried out in strict compliance with the approved 
guidelines. The baseline studies were carried out initially at 
Delhi (~290 m, B), thereafter all the volunteers were flown to 
Bishkek, Kyrgyzstan (~800 m, A1). All variables were studied 
after 3 days of stay at 800 m. This was followed by induction 
to an altitude of 3200 m (Tuya Ashu Pass, Kyrgyzstan, A2) 
by a road journey and variables were recorded there at day 10 
(A2-D10) and day 20 (A2-D20) of high altitude exposure. All 
the volunteers were provided with proper winter clothing and 
got involved in mild indoor activities with room temperature at 
22 oC ± 2 oC. After induction to altitude, proper acclimatisation 
schedule was followed before starting any measurements. 
Thereafter all the volunteers were de-induced to 800 m (DI-
A1) by road and to 290 m (DI-B) by air. All the variables were 
again repeated after 3 days of de-induction. All measurements 
were performed at approximately similar time during each test 
day and by the same instructor.
2.  acute MountaIn sIcKness  
Lake Louise Score system was used to assess acute 
mountain sickness (AMS)  which is based on presence of 
following symptoms: headache, dizziness, gastrointestinal 
distress (loss of appetite, nausea, or vomiting), fatigue and 
insomnia. Each item was scored on a scale between 0 and 3 by 
the volunteers (0 = none, 1 = mild, 2 = moderate, 3 = severe).
3.  blood Pressure and heart rate  
MeasureMent
Systolic and diastolic blood pressure along with heart rate 
was measured in volunteers using mercury free BP instrument 
(OMRON®, USA). Measurements were taken in supine 
position after volunteers were rested for at least 15 min. Blood 
pressure (BP) and heart rate (HR) were taken at similar time at 
each time point during the study.
4.  body WeIght and heIght 
MeasureMent
Body weight was measured in the morning before 
breakfast after voiding using electronic balance (Deca 770, 
Seca Corporation, USA). Body weight was taken at similar time 
at each time point during the study. For height measurement, a 
calibrated height rod was used (Medical Scale and Measuring 
System, Birmingham, UK) and proper instructions were given 
before recording.
5.  arterIal oxygen saturatIon 
MeasureMent
Saturation of peripheral oxygen (SpO2) was measured 
using finger pulse oximeter (Nonin Medical Inc. USA).
6.  lung FunctIon tests
Portable Spirometer (Pony FX, COSMED, Italy) was 
used for measuring forced vital capacity (FVC), forced 
expiratory volume in 1 s (FEV1), FEV1/FVC ratio, average 
mid expiratory flow (FEF 25 % - 75 %), maximal expiratory 
flow rate when 25 per cent of FVC remains to be exhaled 
(MEF 25 %), maximal expiratory flow rate when 75 per cent 
of FVC remains to be exhaled (MEF 75 %), peak expiratory 
flow (PEF) and maximum voluntary ventilation (MVV). The 
test was performed at least two hours after a meal. Instructions 
were clearly explained to each volunteer and were made 
to rest for minimum 15 m before starting the procedure. All 
measurements were done in standing position with nose clip. 
Total of three manoeuvres were obtained of which minimum 
two meet repeatability criteria (<0.15 L variability for FVC 
and FEV1). A good seal around mouthpiece, no obstruction to 
the mouthpiece, no glottis closure, no premature termination 
and wearing nose clips were ensured during each effort.
7.  statIstIcal analysIs
Data were represented as Mean ± SEM. The data were 
analysed using Prism 5 software (Graph Pad Prism 6, USA). 
To compare the changes in same group in different phases, data 
was analysed using one way analysis of variance (ANOVA) 
with repeated measure and Post hoc testing with Bonferroni 
multiple comparison test. P value <0.05 was considered 
significant.
8.  results
Systolic blood pressure increased significantly (p<0.01) 
upon HA induction at day 10 (122 mm Hg ± 1.71 mm Hg) and 
day 20 (120 mm Hg ±2.05 mm Hg) compared to basal (117 
mm Hg ±1.72 mm Hg) and 800 m (117 mm Hg ± 1.85 mm 
Hg). Similarly, diastolic blood pressure increased significantly 
(p<0.001) upon HA induction at day 10 (76 mm Hg ±1.41 mm 
Hg) and day 20 (72 mm Hg ±1.63 mm Hg) compared to basal 
(66 mm Hg ±1.41 mm Hg) and 800 m (66 mm Hg ±1.52 mm 
Hg). Both systolic and diastolic BP returned to normal after 
de-induction. HR increased significantly (p<0.05) upon HA 
exposure at day 10 (68 beats/min ±1.75 beats/min) compared to 
basal (63 beats/min ±1.73 beats/min) and 800 m (64 beats/min 
±1.81 beats/min) and returned to similar values as basal upon 
de-induction (64 beats/min ±1.7 beats/min). SpO2 decreased 
significantly upon high altitude inductionand restored upon 
de-induction as shown in Fig. 1. Additionally, the AMS score 
based had all values less than 2 for all the volunteers.
FVC decreased upon HA induction to day 10 (4.72 litres 
± 0.18 litres) compared to basal (4.81 litres ± 0.18 litres) and 
returned to basal values upon de-induction. FEV1/FVC ratio 
increased at day 10 (80.29 % ±1.42 %) of exposure compared 
to basal (79 % ± 1.34 %). FEF25-75 per cent increased upon 
day 10 (3.92 L/s ± 0.25 L/s) and day 20(4.23 L/s ± 0.42 L/s) of 
induction to mountain compared to basal (3.57 L/s ± 0.24 L/s) 
and 800 m (3.68 L/s ± 0.21 L/s) and returned to basal values 
upon de-induction. MVV values increased upon induction to 
high altitude by 16.8 per cent and 18 per cent at day 10 and 20 
respectively compared to basal and returned to basal three days 
after de-induction as shown in Fig. 2. 
MEF 25 % increased upon HA induction with significant 
increase at day 20 (1.86 L/s ± 0.15L/s) compared to basal (1.68 
L/s ± 0.12 L/s). MEF 50 per cent increased significantly upon 
induction to day 10 (4.84 L/s ± 0.36 L/s) and day 20 (4.96 L/s 
± 0.37 L/s) of HA compared to basal (4.50 L/s ± 0.32 L/s)and 
800m (4.60 L/s ± 0.32 L/s) and returned to basal values upon 
de-induction. MEF75 per cent increased significantly upon 
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Figure 2. changes in (a) FVc, (b) FeV1/FVc, (c) FeF 25-75%, (d) FeV1, (e) MVV at different time points in Indian volunteers. 
Values are mean ± SEM and ** = p≤0.01 and *** = p≤ 0.001 as compared to basal.
(a) (b) (c)
(d) (e)
Figure 1. changes in (a) systolic blood pressure, (b) diastolic blood pressure, (c) heart rate, (d) 
spo2 at different time points in Indian volunteers. Values are mean ± seM and  *** = 
p≤ 0.001 as compared to basal.
(a) (b)
(c) (d)
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(a) (b)
Figure 3.  Changes in (a) MEF 25 %, (b) MEF 50 %, (c) MEF 75 %, (d) PEF at different 
time points in Indian volunteers. Values are mean ± SEM and * = p≤0.05, 
** = p≤0.01 and *** = p≤ 0.001 as compared to basal.
(c) (d)
day 10 (8.11 L/s ± 0.43 L/s) of exposure to HA compared to 
basal (7.14 L/s ± 0.41 L/s) and 800 m (7.48 L/s ± 0.4 L/s) and 
returned to baseline upon de-induction. Peak expiratory flow 
too increased at day 10 (10.43 L/s ± 0.38 L/s) and 21 (10.67 L/s 
±0.34 L/s) and returned to baseline upon de-induction (9.85 
L/s ± 0.3 L/s) as shown in Figs. 3 (b) - 3(d).
9.  dIscussIon
In the present study we have reported changes in BP, HR, 
FVC, FEV1, FVC/FEV1, FEF 25 % -75 %, MEF 25 %, MEF 50 
%, MEF 75 %, MVV and peak expiratory flow in lowlanders 
at basal and at different altitude durations of high altitude stay. 
This is one of the few studies where measurements of variables 
in Indian soldiers are done in a different geographical region at 
different altitudes. These kinds of studies could be helpful for 
understanding respiratory function in the soldiers who are posted 
or visit different altitudes for various purposes. Pulmonary 
function tests (PFTs) include spirometry which measures 
the function of lung and is an important respiratory function 
parameter. It measures emptying and filling of lungs during a 
slow or forceful manoeuvre and also tests respiratory muscle 
strength1,7. It generates pneumotachographs from volume and 
flow of inspired and expired air. FVC is the maximum amount 
of air which can be inspired or expired during a maximal effort. 
FEV1 is the volume which expired by the person in one second 
after a maximal inspiration. FEV1 reflects 
both small and larger airway function10 
and did not change much upon altitude 
induction11, which is also reflected in our 
study. FEV1/FVC ratio gives an index 
for airflow limitation8. Low FEV1/FVC 
ratio indicate an obstructive abnormality 
like in case of asthma or emphysema. 
Higher or normal FEV1/FVC ratio with 
lower FVC indicates restrictive ventilation 
abnormality like in respiratory muscle 
weakness, interstitial lung disease7,8. In the 
past, studies (both field and simulated) have 
shown to decrease FVC in high altitude 
regions of Nepal and Alps12. At 4559 m a 
decrease has been found in FVC in both 
normal and HAPE patients as compared 
to basal13. Acute mountain sickness has 
been known to decrease FEV1, FEF25 
per cent -75 per cent and FVC upon high 
altitude exposure14. A number of studies 
have shown that high altitude environment 
reduces FVC, FEV1 and MVV, but there 
have been contradictions too6,9,11,12,15-17. 
FVC and FEV1 at an altitude of 3110 m 
did not change upon initial exposure and 
declined upon further exposure to 3445 m 
and 4177 m1. In our study we have found 
a decrease in FVC upon HA exposure with 
significant decrease at day 10 and returned 
almost normal upon de-induction which 
may be due to early closure of airways. 
FEV1/FVC increased significantly upon 
day10 of HA induction as compared to basal, but no change 
when compared to 800 m. This increase in the FEV1/FVC ratio 
is due to no change in FEV1 upon high altitude and fall in 
FVC. FEF25 per cent - 75 per cent is the mid maximal expired 
air flow and is measure of small airway function and in our 
study its value increased upon HA induction and returning to 
normal after de-induction. Forced expiratory flow values have 
increased upon high altitude exposure in our study probably 
due to reduced airway resistance. If FEV1/FVC ratio is less 
than 5th percentile of predicted value in the volunteer, then it’s a 
possible marker of a ventilatory obstructive effect. In our study 
none of the case was found within this criterion. MEF 25 per 
cent is the flow rate when 25 per cent of FVC is remaining in the 
lungs and is an indicator of small airway function. MEF 75 per 
cent is the flow rate when 75 per cent of FVC is remaining and 
it reflects fairly large to medium size bronchi condition10. MEF 
50 per cent is the flow rate when half of FVC is remaining and 
is indicative of small to medium airway function10,18. Wolf19 , et 
al. reported MEF 50 per cent and MEF 75 per cent increased 
with increasing altitude of 1580 m as compared to 171 m with 
a mean 11 per cent and 15 per cent rise respectively19. Similar 
results are reflected in our study upon altitude induction. MEF 
25 per cent shows decrease upon initial exposure to high altitude 
and increased upon further stay at 3500 m12. This increase may 
be due to reduction in air density causing less air resistance 
311
SAINI, et al.: DEF. LIFE SCI. J., VOL. 3, NO. 3, JULy 2018, DOI : 10.14429/DLSJ.3.12404
which accelerates lung emptying15. In the present study no 
significant change in MEF 25 per cent was observed at day 10 
of induction, though value increased upon HA induction to day 
20 and returned to normal upon de-induction. This increase 
at day 20 may be due to respiratory adaptation pertaining to 
greater duration of stay at high altitude. PEF is the maximal 
expiratory flow rate in a forced manoeuvre18,20. PEF has been 
reported to be consistently improved at 2800 m, 4267 m, and 
5300 m compared to basal16,21,22. At a similar altitude (3200), 
PEF is known to linearly increase12 which is also reflected in our 
study. MVV is also called as maximum breathing capacity and 
is generally measured for 12 s to 15  s to evaluate respiratory 
muscle endurance. It correlates to FEV1 multiplied by 35 and 
can be used if the person is not comfortable in performing 
MVV test oxygen cost of breathing at high altitude is 26 per 
cent of maximal oxygen capacity, which is only 5.5 per cent 
at basal23. This means that work of breathing increases at high 
altitude which also affects respiratory muscles and it’s a marker 
of respiratory muscle endurance. There has been contradicting 
studies in MVV upon high altitude exposure. While few 
field and hypobaric hypoxia chamber studies have found an 
improved MVV24-27, some have reported a decrement in its 
value1,11. In our present study we found increased maximum 
voluntary ventilation which may be due to us following of 
proper acclimatization in the volunteers and taking the first 
measurement after 10 days at altitude. Consequences of high 
altitude on lung and spirometry variables in human soldiers 
in different altitude regions are essential and interesting area 
of research and can be correlated further with other important 
acclimatisation parameters.
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